Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192

Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192What is this standard about? This document provides guidance for ancillary material (AM) users. It is applicable to cellular therapeutic products, including those gene therapy products whereby cells form part of the final product. It does not apply to products without cells. This document focuses primarily on ancillary materials (AMs) of biological (human and animal) origin and their potential impurities and contaminants. NOTE 1 The decision chart in

Medical institutions and organisations

and those manufactured from other isotropic

as defined in BS EN ISO 11553-1:2008

Why should you use ISO 14122-2-General requirements for working platforms and walkways

terms and conditions of employment

This European Standard supersedes BS EN 50016:2002 which will be withdrawn in June 2007

based on high performance liquid chromatography (HPLC)

2 Fixings and materials not supplied by the manufacturer

and for the protection of structures near trees

It also applies to hollow sections formed hot with or without subsequent heat treatment or formed cold with subsequent heat treatment to obtain equivalent metallurgical conditions to

Annex B (informative) Example of a report — Sampling from groundwaters

Who is BS EN 15436-1 - Road service maintenance equipment terminology for